loadpatents
name:-0.019691944122314
name:-0.008397102355957
name:-0.0029048919677734
Dasse; Olivier Patent Filings

Dasse; Olivier

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dasse; Olivier.The latest application filed is for "deuterated analogs of etifoxine, their derivatives and uses thereof".

Company Profile
1.6.16
  • Dasse; Olivier - Foothills Ranch CA
  • Dasse; Olivier - Foothill Ranch CA
  • Dasse; Olivier - Marlborough MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Deuterated Analogs Of Etifoxine, Their Derivatives And Uses Thereof
App 20200405726 - Dasse; Olivier
2020-12-31
Deuterated analogs of etifoxine, their derivatives and uses thereof
Grant 10,736,901 - Dasse A
2020-08-11
Deuterated Analogs Of Etifoxine, Their Derivatives And Uses Thereof
App 20190015419 - Dasse; Olivier
2019-01-17
Deuterated analogs of etifoxine, their derivatives and uses thereof
Grant 10,080,755 - Dasse September 25, 2
2018-09-25
Deuterated Analongs Of Etifoxine, Their Derivatives And Uses Thereof
App 20180064717 - Dasse; Olivier
2018-03-08
Alpha 7 Nicotinic Acetylcholine Receptor Allosteric Modulators, Their Derivatives and Uses Thereof
App 20150099758 - Putnam; David ;   et al.
2015-04-09
Enantiomerically pure S-etifoxine, pharmaceutical compositions thereof and methods of their use
Grant 8,110,569 - Putman , et al. February 7, 2
2012-02-07
Synthesis, polymorphs, and pharmaceutical formulation of FAAH inhibitors
Grant 7,888,394 - Putman , et al. February 15, 2
2011-02-15
Methods For Treating Energy Metabolism Disorders By Inhibiting Fatty Acid Amide Hydrolase Activity
App 20090099240 - Parrott; Jeff A. ;   et al.
2009-04-16
Synthesis, Polymorphs, And Pharmaceutical Formulation Of Faah Inhibitors
App 20090030074 - Putman; David ;   et al.
2009-01-29
Metabolically-stabilized Inhibitors Of Fatty Acid Amide Hydrolase
App 20080119549 - DASSE; Olivier ;   et al.
2008-05-22
Methods For Determining Effective Doses Of Fatty Acid Amide Hydrolase Inhibitors In Vivo
App 20080089845 - Compton; Timothy R. ;   et al.
2008-04-17
Combination Faah Inhibitor And Analgesic, Anti-inflammatory Or Anti-pyretic Agent
App 20080045513 - DASSE; Olivier
2008-02-21
Enantiomerically pure S-etifoxine, pharmaceutical compositions thereof and methods of their use
App 20080038331 - Putman; David ;   et al.
2008-02-14
Enantiomerically pure R-etifoxine, pharmaceutical compositions thereof and methods of their use
App 20080039453 - Putman; David ;   et al.
2008-02-14
Ionizable Inhibitors Of Fatty Acid Amide Hydrolase
App 20070155707 - Dasse; Olivier ;   et al.
2007-07-05
Inhibitors Of Fatty Acid Amide Hydrolase
App 20070155747 - Dasse; Olivier ;   et al.
2007-07-05
Pyrrolidinone derivatives
Grant 6,936,633 - Zou , et al. August 30, 2
2005-08-30
Pyrrolidinone derivatives
App 20050004180 - Zou, Dong ;   et al.
2005-01-06
Pyrrolidinone derivatives
App 20040157914 - Zou, Dong ;   et al.
2004-08-12
Pyrrolidinone derivatives
Grant 6,727,275 - Zou , et al. April 27, 2
2004-04-27
Pyrrolidinone derivatives
App 20030149081 - Zou, Dong ;   et al.
2003-08-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed